Literature DB >> 12875295

Case report: Rectal adminstration of ivermectin to a patient with Strongyloides hyperinfection syndrome.

Philip E Tarr1, Peter S Miele, Kenneth S Peregoy, Margo A Smith, Franklin A Neva, Daniel R Lucey.   

Abstract

Strongyloides hyperinfection syndrome may be complicated by paralytic ileus that interferes with the absorption of oral anti-helminthics. We report on the administration of ivermectin as a rectal enema preparation to a renal transplant recipient with Strongyloides hyperinfection syndrome and progressive ileus. Attempts at treatment using nasogastric albendazole and ivermectin were unsuccessful despite clamping the nasogastric tube after drug administration. Ivermectin tablets were ground to a powder, resuspended in a commercially available suspending agent, and administered per rectum. The suspending agent was chosen for its near-physiologic osmolality to allow longer retention, in contrast to many enema preparations that have a laxative effect. The patient improved markedly within 72 hours of initiation of the therapy per rectum and recovered fully. Ivermectin administered as an enema may be beneficial in patients with severe strongyloidiasis who are unable to absorb or tolerate oral therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12875295

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  16 in total

1.  Non-oral treatment with ivermectin for disseminated strongyloidiasis.

Authors:  Dahlene N Fusco; Jennifer A Downs; Michael J Satlin; Meera Pahuja; Liz Ramos; Philip S Barie; Lawrence Fleckenstein; Henry W Murray
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

2.  Recurrent Streptococcus bovis meningitis in Strongyloides stercoralis hyperinfection after kidney transplantation: the dilemma in a non-endemic area.

Authors:  Taqi T Khan; Fatehi Elzein; Abdullah Fiaar; Faheem Akhtar
Journal:  Am J Trop Med Hyg       Date:  2014-01-06       Impact factor: 2.345

3.  Strongyloidiasis: a multifaceted disease.

Authors:  Swaytha Ganesh; Ruy J Cruz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-03

4.  Failure of ivermectin per rectum to achieve clinically meaningful serum levels in two cases of Strongyloides hyperinfection.

Authors:  Isaac I Bogoch; Kamran Khan; Howard Abrams; Caroline Nott; Elizabeth Leung; Lawrence Fleckenstein; Jay S Keystone
Journal:  Am J Trop Med Hyg       Date:  2015-04-27       Impact factor: 2.345

5.  Fatal strongyloidiasis in an immunocompromised HTLV-I infected patient.

Authors:  Michiel Peter de Boer; Christianne Bethlem-Schaap; Stephen de Jager; Elsbeth Wesselink; Ian Ambrose; Cornelis Slagt
Journal:  Intensive Care Med       Date:  2012-10-30       Impact factor: 17.440

6.  Emerging parasitic infections in transplantation.

Authors:  Roberta Lattes; Laura Linares; Marcelo Radisic
Journal:  Curr Infect Dis Rep       Date:  2012-12       Impact factor: 3.725

7.  Update on strongyloidiasis in the immunocompromised host.

Authors:  Luis A Marcos; Angélica Terashima; Marco Canales; Eduardo Gotuzzo
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

8.  Duodenal obstruction - an unusual presentation of Strongyloides stercoralis enteritis: a case report.

Authors:  Ruy J Cruz; Rodrigo Vincenzi; Bernardo M Ketzer
Journal:  World J Emerg Surg       Date:  2010-08-10       Impact factor: 5.469

Review 9.  Strongyloidiasis in transplant patients.

Authors:  Alison C Roxby; Geoffrey S Gottlieb; Ajit P Limaye
Journal:  Clin Infect Dis       Date:  2009-11-01       Impact factor: 9.079

Review 10.  Severe strongyloidiasis: a systematic review of case reports.

Authors:  Dora Buonfrate; Ana Requena-Mendez; Andrea Angheben; Jose Muñoz; Federico Gobbi; Jef Van Den Ende; Zeno Bisoffi
Journal:  BMC Infect Dis       Date:  2013-02-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.